Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$112.0M
total disclosed, rounds participated
Stages
—
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Casdin Capital's most recent notable exit?
- Casdin Capital had a notable exit in January 2024 when C2i Genomics, a whole-genome cancer treatment intelligence platform, was acquired by Veracyte for $95M.
- Which sectors does Casdin Capital primarily focus on for investments?
- Casdin Capital shows a strong focus on the Health Tech & Life Sciences sector, with all its recorded portfolio companies and exits falling within this area.
- Can you name a key portfolio company for Casdin Capital?
- A key portfolio company for Casdin Capital is C2i Genomics, a whole-genome cancer treatment intelligence platform that was acquired in January 2024.
- What is Casdin Capital's typical investment range?
- Casdin Capital typically invests in the range of $12M to $100M.
- What funding stages does Casdin Capital participate in?
- Casdin Capital has participated in A Round and B Round funding stages.